Cargando…

Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity

Identifying genetic modifiers of familial amyotrophic lateral sclerosis (ALS) may reveal targets for therapeutic modulation with potential application to sporadic ALS. GGGGCC (G4C2) repeat expansions in the C9orf72 gene underlie the most common form of familial ALS, and generate toxic arginine-conta...

Descripción completa

Detalles Bibliográficos
Autores principales: Bennett, Craig L., Dastidar, Somasish, Arnold, Frederick J., McKinstry, Spencer U., Stockford, Cameron, Freibaum, Brian D., Sopher, Bryce L., Wu, Meilin, Seidner, Glen, Joiner, William, Taylor, J. Paul, West, Ryan J. H., La Spada, Albert R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580588/
https://www.ncbi.nlm.nih.gov/pubmed/37845749
http://dx.doi.org/10.1186/s40478-023-01665-z
_version_ 1785121974044852224
author Bennett, Craig L.
Dastidar, Somasish
Arnold, Frederick J.
McKinstry, Spencer U.
Stockford, Cameron
Freibaum, Brian D.
Sopher, Bryce L.
Wu, Meilin
Seidner, Glen
Joiner, William
Taylor, J. Paul
West, Ryan J. H.
La Spada, Albert R.
author_facet Bennett, Craig L.
Dastidar, Somasish
Arnold, Frederick J.
McKinstry, Spencer U.
Stockford, Cameron
Freibaum, Brian D.
Sopher, Bryce L.
Wu, Meilin
Seidner, Glen
Joiner, William
Taylor, J. Paul
West, Ryan J. H.
La Spada, Albert R.
author_sort Bennett, Craig L.
collection PubMed
description Identifying genetic modifiers of familial amyotrophic lateral sclerosis (ALS) may reveal targets for therapeutic modulation with potential application to sporadic ALS. GGGGCC (G4C2) repeat expansions in the C9orf72 gene underlie the most common form of familial ALS, and generate toxic arginine-containing dipeptide repeats (DPRs), which interfere with membraneless organelles, such as the nucleolus. Here we considered senataxin (SETX), the genetic cause of ALS4, as a modifier of C9orf72 ALS, because SETX is a nuclear helicase that may regulate RNA–protein interactions involved in ALS dysfunction. After documenting that decreased SETX expression enhances arginine-containing DPR toxicity and C9orf72 repeat expansion toxicity in HEK293 cells and primary neurons, we generated SETX fly lines and evaluated the effect of SETX in flies expressing either (G4C2)(58) repeats or glycine-arginine-50 [GR(50)] DPRs. We observed dramatic suppression of disease phenotypes in (G4C2)(58) and GR(50) Drosophila models, and detected a striking relocalization of GR(50) out of the nucleolus in flies co-expressing SETX. Next-generation GR(1000) fly models, that show age-related motor deficits in climbing and movement assays, were similarly rescued with SETX co-expression. We noted that the physical interaction between SETX and arginine-containing DPRs is partially RNA-dependent. Finally, we directly assessed the nucleolus in cells expressing GR-DPRs, confirmed reduced mobility of proteins trafficking to the nucleolus upon GR-DPR expression, and found that SETX dosage modulated nucleolus liquidity in GR-DPR-expressing cells and motor neurons. These findings reveal a hitherto unknown connection between SETX function and cellular processes contributing to neuron demise in the most common form of familial ALS. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-023-01665-z.
format Online
Article
Text
id pubmed-10580588
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105805882023-10-18 Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity Bennett, Craig L. Dastidar, Somasish Arnold, Frederick J. McKinstry, Spencer U. Stockford, Cameron Freibaum, Brian D. Sopher, Bryce L. Wu, Meilin Seidner, Glen Joiner, William Taylor, J. Paul West, Ryan J. H. La Spada, Albert R. Acta Neuropathol Commun Research Identifying genetic modifiers of familial amyotrophic lateral sclerosis (ALS) may reveal targets for therapeutic modulation with potential application to sporadic ALS. GGGGCC (G4C2) repeat expansions in the C9orf72 gene underlie the most common form of familial ALS, and generate toxic arginine-containing dipeptide repeats (DPRs), which interfere with membraneless organelles, such as the nucleolus. Here we considered senataxin (SETX), the genetic cause of ALS4, as a modifier of C9orf72 ALS, because SETX is a nuclear helicase that may regulate RNA–protein interactions involved in ALS dysfunction. After documenting that decreased SETX expression enhances arginine-containing DPR toxicity and C9orf72 repeat expansion toxicity in HEK293 cells and primary neurons, we generated SETX fly lines and evaluated the effect of SETX in flies expressing either (G4C2)(58) repeats or glycine-arginine-50 [GR(50)] DPRs. We observed dramatic suppression of disease phenotypes in (G4C2)(58) and GR(50) Drosophila models, and detected a striking relocalization of GR(50) out of the nucleolus in flies co-expressing SETX. Next-generation GR(1000) fly models, that show age-related motor deficits in climbing and movement assays, were similarly rescued with SETX co-expression. We noted that the physical interaction between SETX and arginine-containing DPRs is partially RNA-dependent. Finally, we directly assessed the nucleolus in cells expressing GR-DPRs, confirmed reduced mobility of proteins trafficking to the nucleolus upon GR-DPR expression, and found that SETX dosage modulated nucleolus liquidity in GR-DPR-expressing cells and motor neurons. These findings reveal a hitherto unknown connection between SETX function and cellular processes contributing to neuron demise in the most common form of familial ALS. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-023-01665-z. BioMed Central 2023-10-17 /pmc/articles/PMC10580588/ /pubmed/37845749 http://dx.doi.org/10.1186/s40478-023-01665-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Bennett, Craig L.
Dastidar, Somasish
Arnold, Frederick J.
McKinstry, Spencer U.
Stockford, Cameron
Freibaum, Brian D.
Sopher, Bryce L.
Wu, Meilin
Seidner, Glen
Joiner, William
Taylor, J. Paul
West, Ryan J. H.
La Spada, Albert R.
Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity
title Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity
title_full Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity
title_fullStr Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity
title_full_unstemmed Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity
title_short Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity
title_sort senataxin helicase, the causal gene defect in als4, is a significant modifier of c9orf72 als g4c2 and arginine-containing dipeptide repeat toxicity
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580588/
https://www.ncbi.nlm.nih.gov/pubmed/37845749
http://dx.doi.org/10.1186/s40478-023-01665-z
work_keys_str_mv AT bennettcraigl senataxinhelicasethecausalgenedefectinals4isasignificantmodifierofc9orf72alsg4c2andargininecontainingdipeptiderepeattoxicity
AT dastidarsomasish senataxinhelicasethecausalgenedefectinals4isasignificantmodifierofc9orf72alsg4c2andargininecontainingdipeptiderepeattoxicity
AT arnoldfrederickj senataxinhelicasethecausalgenedefectinals4isasignificantmodifierofc9orf72alsg4c2andargininecontainingdipeptiderepeattoxicity
AT mckinstryspenceru senataxinhelicasethecausalgenedefectinals4isasignificantmodifierofc9orf72alsg4c2andargininecontainingdipeptiderepeattoxicity
AT stockfordcameron senataxinhelicasethecausalgenedefectinals4isasignificantmodifierofc9orf72alsg4c2andargininecontainingdipeptiderepeattoxicity
AT freibaumbriand senataxinhelicasethecausalgenedefectinals4isasignificantmodifierofc9orf72alsg4c2andargininecontainingdipeptiderepeattoxicity
AT sopherbrycel senataxinhelicasethecausalgenedefectinals4isasignificantmodifierofc9orf72alsg4c2andargininecontainingdipeptiderepeattoxicity
AT wumeilin senataxinhelicasethecausalgenedefectinals4isasignificantmodifierofc9orf72alsg4c2andargininecontainingdipeptiderepeattoxicity
AT seidnerglen senataxinhelicasethecausalgenedefectinals4isasignificantmodifierofc9orf72alsg4c2andargininecontainingdipeptiderepeattoxicity
AT joinerwilliam senataxinhelicasethecausalgenedefectinals4isasignificantmodifierofc9orf72alsg4c2andargininecontainingdipeptiderepeattoxicity
AT taylorjpaul senataxinhelicasethecausalgenedefectinals4isasignificantmodifierofc9orf72alsg4c2andargininecontainingdipeptiderepeattoxicity
AT westryanjh senataxinhelicasethecausalgenedefectinals4isasignificantmodifierofc9orf72alsg4c2andargininecontainingdipeptiderepeattoxicity
AT laspadaalbertr senataxinhelicasethecausalgenedefectinals4isasignificantmodifierofc9orf72alsg4c2andargininecontainingdipeptiderepeattoxicity